Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China · Delayed Price · Currency is CNY 54.35
+0.77 (1.44%)
At close: Aug 4, 2026
Cofoe Medical Technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,662 | 3,387 | 2,983 | 2,854 | 2,977 | 2,276 |
Revenue Growth | 25.69% | 13.56% | 4.53% | -4.14% | 30.82% | -4.19% |
Gross Profit Gross Profit Growth | 1,942 | 1,768 | 1,515 | 1,184 | 1,137 | 979.57 |
Operating Income Operating Income Growth | 353.75 | 334.51 | 309.35 | 210.31 | 251.23 | 420.89 |
Net Income Net Income Growth | 387.23 | 371.61 | 311.75 | 254.28 | 301.68 | 428.86 |
Earnings Per Share EPS Growth | 1.88 | 1.81 | 1.51 | 1.24 | 1.45 | 2.60 |
EPS Growth | 28.83% | 19.87% | 21.77% | -14.48% | -44.23% | -4.25% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Rehabilitation Assistive Products Rehabilitation Assistive Products Growth | 1,244 | 1,104 | 772.98 | 592.48 | 414.58 |
Medical Care Products Medical Care Products Growth | 911.65 | 801.36 | 740.46 | 1,099 | 765.03 |
Health Monitoring Products Health Monitoring Products Growth | 586.89 | 488.76 | 586.78 | 786.07 | 553.94 |
Respiratory Support Products Respiratory Support Products Growth | 265.33 | 267.11 | 455.43 | 237.95 | 199.63 |
Traditional Chinese Medicine and Other Products Traditional Chinese Medicine and Other Products Growth | 244.22 | 180.71 | 150.02 | - | - |
Unallocated Other Business Income Unallocated Other Business Income Growth | 135.86 | 141.38 | 148.02 | - | - |
Total Total Growth | 3,387 | 2,983 | 2,854 | 2,977 | 2,276 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,671 | 2,439 | 2,636 | 2,421 | 2,693 | 3,527 |
Total Debt Total Debt Growth | 1,021 | 826.18 | 903.4 | 640.77 | 462.82 | 233.15 |
Net Cash (Debt) Net Cash Growth | 1,650 | 1,612 | 1,733 | 1,780 | 2,231 | 3,293 |
Net Cash Growth | -6.30% | -6.95% | -2.65% | -20.20% | -32.27% | 1133.06% |
Net Cash Per Share Net Cash Per Share Growth | 8.01 | 7.85 | 8.42 | 8.69 | 10.70 | 20.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 688.23 | 695.73 | 663.39 | 393.82 | 98.91 | 239.99 |
Capital Expenditures CapEx Growth | -142.72 | -178.1 | -120.5 | -373.22 | -639.79 | -513.24 |
Free Cash Flow Free Cash Flow Growth | 545.51 | 517.63 | 542.9 | 20.6 | -540.87 | -273.25 |
Free Cash Flow Growth | 40.16% | -4.65% | 2535.66% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 53.03% | 52.20% | 50.79% | 41.48% | 38.21% | 43.05% |
Operating Margin | 9.66% | 9.88% | 10.37% | 7.37% | 8.44% | 18.50% |
Pretax Margin | 12.16% | 12.57% | 12.47% | 10.01% | 11.23% | 22.34% |
Profit Margin | 10.57% | 10.97% | 10.45% | 8.91% | 10.13% | 18.85% |
FCF Margin | 14.90% | 15.28% | 18.20% | 0.72% | -18.17% | -12.01% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.800 | 1.800 | 1.800 | 1.200 | 1.200 | 1.231 |
Dividend Per Share Growth | 0% | 0% | 50.00% | 0% | -2.50% | - |
Dividend Yield | 3.36% | 4.12% | 5.47% | 3.57% | 3.81% | 2.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 28.48 | 24.43 | 23.07 | 30.64 | 25.21 | 29.44 |
Forward PE | 25.35 | 21.45 | - | - | - | - |
P/FCF Ratio | 21.59 | 17.54 | 13.25 | 378.22 | - | - |
PS Ratio | 3.22 | 2.68 | 2.41 | 2.73 | 2.56 | 5.55 |